2004
DOI: 10.1158/0008-5472.can-04-0756
|View full text |Cite
|
Sign up to set email alerts
|

Genomic and Expression Profiling of Chromosome 17 in Breast Cancer Reveals Complex Patterns of Alterations and Novel Candidate Genes

Abstract: Chromosome 17 is severely rearranged in breast cancer. Whereas the short arm undergoes frequent losses, the long arm harbors complex combinations of gains and losses. In this work we present a comprehensive study of quantitative anomalies at chromosome 17 by genomic arraycomparative genomic hybridization and of associated RNA expression changes by cDNA arrays. We built a genomic array covering the entire chromosome at an average density of 1 clone per 0.

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
85
1
1

Year Published

2004
2004
2010
2010

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 84 publications
(93 citation statements)
references
References 22 publications
(22 reference statements)
6
85
1
1
Order By: Relevance
“…Most importantly, this approach circumvents limitations of previous analysis, as it takes into account (1) the possible existence of multiple cores in a single amplicon and (2) the hypothesis that each amplicon contains more than one amplicon driver. It should be noted, however, that STARD3 and GRB7, two of the most commonly overexpressed genes in the HER2 amplicon (17q12-q21) in previous studies [4,44], failed to display a significant correlation between amplification and overexpression, owing to the suboptimal performance of the respective cDNA probes. Similar analyses were performed for other recurrent amplicons in these cell lines and genes that may be considered as potential amplicon drivers for each amplicon are described in Supplementary Table S6.…”
Section: Identification Of Likeliest Amplicon Drivers Of Recurrent Ammentioning
confidence: 83%
“…Most importantly, this approach circumvents limitations of previous analysis, as it takes into account (1) the possible existence of multiple cores in a single amplicon and (2) the hypothesis that each amplicon contains more than one amplicon driver. It should be noted, however, that STARD3 and GRB7, two of the most commonly overexpressed genes in the HER2 amplicon (17q12-q21) in previous studies [4,44], failed to display a significant correlation between amplification and overexpression, owing to the suboptimal performance of the respective cDNA probes. Similar analyses were performed for other recurrent amplicons in these cell lines and genes that may be considered as potential amplicon drivers for each amplicon are described in Supplementary Table S6.…”
Section: Identification Of Likeliest Amplicon Drivers Of Recurrent Ammentioning
confidence: 83%
“…Inversions are difficult to detect but are an attractive explanation for the amplification of apparently distinct regions of one chromosome (e.g. Orsetti et al, 2004): inversion, creating an oncogenic junction, would be followed by amplification of one inversion junction, manifest as two apparent regions of amplification by array CGH, in the same way as amplifications on distinct chromosomes can be coamplifications (Guan et al, 1994;Bautista and Theillet, 1998;Volik et al, 2003).…”
Section: Inversionsmentioning
confidence: 99%
“…Coverage of chromosomes 8 and 17 has been described by Orsetti et al (2004) and Gelsi-Boyer et al (2005). Chromosome 1 was covered by 257 BAC clones selected as follows: 225 BAC clones from the Barbara Trask collection (CHORI) http://www.ncbi.nlm.…”
Section: Genomic Arraysmentioning
confidence: 99%
“…Probe DNA to be spotted was prepared by DOP-PCR amplification on 10 ng of BAC matrix DNA in a final reaction volume of 100 ml. Primer sequences and DOP-PCR protocol used are available on the Sanger Center web site (http://www.sanger.ac.uk/HGP/methods/cytogenetics/ DOPPCR.shtml) (Orsetti et al, 2004). We performed this with slight modifications: the second round DOP-PCR primer was not aminolinked.…”
Section: Genomic Arraysmentioning
confidence: 99%